生命科学资讯

Takeda 'anticipated' Medicare negotiations for top seller Entyvio

Takeda is ‘not in favor’ of Trump’s MFN deals, CEO-designate says

White House postpones planned TrumpRx launch event

Sanofi vows to stay committed to vaccines as portfolio takes a hit

The disrupted fate of pharmacy startups

Sanofi's pipeline cuts; Breakthru Medicine raises $60M

Summit gets November PDUFA date for its PD-1xVEGF bispecific

Trump looks to raise South Korea levies; Siegfried expands

Agomab anticipates $182M IPO as it builds fibrosis pipeline

AstraZeneca makes $15B bet on China to expand manufacturing and R&D

Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliff

Flagship's Repertoire gets another autoimmune partner in Lilly

Tenpoint gets FDA nod for presbyopia eye drop and $235M

ChenMed CEO warns against GLP-1s for seniors

Round three of IRA negotiations is expected to be ‘manageable’ for pharma

Oral Rogaine maker Veradermics looks to raise $181M from IPO

FDA asks court to pause Louisiana's abortion pill fight

Lonza still intends to sell its capsules and health ingredients business

Lonza still intends to sell its capsules and health ingredients business - Endpoints News

Teva CEO says it has successfully transitioned into a biopharma company